Frontline Doctors Credits Informed Patients, Public Pressure with Expanding Access to Early COVID Treatments

Frontline Doctors Credits Informed Patients, Public Pressure with Expanding Access to Early COVID Treatments

AFLDS fought for ‘sea change’ in outpatient therapies, including HCQ and ivermectin

Los Angeles, CA – America’s Frontline Doctors (AFLDS) today applauded recent federal changes related to the use of repurposed safe and effective medications for early treatment of COVID-infected patients. In particular, AFLDS credited its mobilization of concerned citizens through public-awareness campaigns with reversals by major public health entities such as the National Institutes of Health (NIH) concerning the FDA-approved antiparasitic drug ivermectin and the American Medical Association’s evolving position on off-label use of the antimalarial drug hydroxychloroquine (HCQ) for early treatment of non-hospitalized patients. The latter action followed additional supportive evidence outlined in the American Journal of Medical Sciences which found that HCQ is effective against SARS-CoV-2, the virus that causes COVID-19.

In its January 2021 COVID-19 treatment guidelines, NIH upgraded ivermectin’s August 2020 status from “against” to “neither for nor against” and called for more clinical trials. AFLDS has been recommending ivermectin for many months as a safe and effective COVID-19 therapy. In study after study, the drug has been associated with improved health outcomes in both COVID-symptomatic patients and those using the drug as a preventive therapy. Approximately 4 billion doses of ivermectin have been administered to patients worldwide.

“We have been advocating for greater access to safe, effective, and low-cost COVID treatments since the pandemic began,” said AFLDS member-physicians. “Untold numbers of Americans have tragically died as a result of official inaction and medical cancel culture by the media and Big Tech. Now, with a sea change happening at the federal level, AFLDS encourages more states’ medical and pharmacy boards to revisit their unscientific opposition to these early forms of treatment and finally make them widely available so that patients can make their own informed healthcare decisions in consultation with a physician.”

Scroll to Top

Sharing a story can change the world.